Radiogenomics and Radioproteomics for Precision Medicine

Abstract

Advancements in post-genome researches have deepened our understanding of molecular biology and enable the detailed subcategorization of diseases. In the cancer treatment, patients are stratified based on genetic information of their cancer, and precision medicine tailored to individual cancer characteristic is been performed. Radiogenomics is the study of estimating cancer’s somatic variants from images, and radioproteomics focuses on estimating protein activity from images. If these studies are successful, it may eliminate invasive biopsies, offer a more cost-effective way, and propose the most suitable treatment options. This paper describes the current state of radiogenomics and radioproteomics researches.